Racial disparities in incidence of cirrhosis and extrahepatic manifestations in metabolic dysfunction-associated steatotic liver disease

被引：0

作者：

Aboona, Majd ^{[1
]}

Ghani, Leith ^{[1
]}

Rangan, Pooja ^{[1
]}

Chen, Vincent ^{[2
]}

Ng, Cheng Han ^{[3
]}

Huang, Daniel ^{[4
]}

Muthiah, Mark ^{[5
]}

Kim, Donghee ^{[6
]}

Rubin, Moises Nevah ^{[7
,8
]}

Han, Ma Ai Thanda ^{[1
,8
]}

Fallon, Michael ^{[1
,8
]}

Wijarnpreecha, Karn ^{[1
,8
,9
]}

机构：

[1] Univ Arizona, Coll Med, Phoenix, AZ USA

[2] Univ Michigan Hlth Syst, Ann Arbor, MI USA

[3] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore

[4] Natl Univ Singapore Hosp, Singapore, Singapore

[5] Natl Univ Hlth Syst, Singapore, Singapore

[6] Stanford Univ, Sch Med, Stanford, CA USA

[7] Univ Arizona, Coll Med, Phoenix, AZ USA

[8] Banner Univ, Med Ctr, Phoenix, AZ USA

[9] Univ Arizona, BIO5 Inst, Coll Med Phoenix, Phoenix, AZ USA

来源：

JOURNAL OF HEPATOLOGY | 2024年 / 80卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

FRI-236-YI

引用

页码：S478 / S478

页数：1

共 50 条

[31] Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease
Polyzos, Stergios A.
Targher, Giovanni
CURRENT OBESITY REPORTS, 2024, 13 (02) : 242 - 255
[32] Racial Disparities in Evidence-Based Management of Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients With Type 2 Diabetes
Alexopoulos, Anastasia-Stefania
Parish, Alice
Olsen, Maren
Batch, Bryan C.
Moylan, Cynthia A.
Crowley, Matthew J.
ENDOCRINE PRACTICE, 2024, 30 (07) : 663 - 669
[33] Mechanobiology in Metabolic Dysfunction-Associated Steatotic Liver Disease and Obesity
Rudolph, Emily L.
Chin, LiKang
CURRENT ISSUES IN MOLECULAR BIOLOGY, 2024, 46 (07) : 7134 - 7146
[34] Phytonanotherapy for the Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease
Nendouvhada, Livhuwani P.
Sibuyi, Nicole R. S.
Fadaka, Adewale O.
Meyer, Samantha
Madiehe, Abram M.
Meyer, Mervin
Gabuza, Kwazikwakhe B.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (11)
[35] Metabolic dysfunction-associated steatotic liver disease and gut microbiota
Petryna, Vitalii
JOURNAL OF HEPATOLOGY, 2024, 80 : S285 - S285
[36] Update in lean metabolic dysfunction-associated steatotic liver disease
Sato-Espinoza, Karina
Chotiprasidhi, Perapa
Huaman, Mariella R.
Diaz-Ferrer, Javier
WORLD JOURNAL OF HEPATOLOGY, 2024, 16 (03) : 452 - 464
[37] Metabolic dysfunction-associated steatotic liver disease: A silent pandemic
Samanta, Arghya
Sen Sarma, Moinak
WORLD JOURNAL OF HEPATOLOGY, 2024, 16 (04)
[38] Postbiotic supplementation for metabolic dysfunction-associated steatotic liver disease
Savytska, Maryana
Baka, Olena
Manzhalii, Elina
Kyriienko, Dmytro
Falalyeyeva, Tetyana
Zhayvoronok, Maksym
Kovalchuk, Oleksandr
Deresh, Nataliya
Grygoriev, Fedir
Kobyliak, Nazarii
JOURNAL OF HEPATOLOGY, 2024, 80 : S610 - S611
[39] Advances in research on metabolic dysfunction-associated steatotic liver disease
Wang, Jiawang
Wang, Zhongyu
Yu, Yao
Cheng, Si
Wu, Jianping
LIFE SCIENCES, 2025, 362
[40] Elucidating cuproptosis in metabolic dysfunction-associated steatotic liver disease
Li, Yamei
Qi, Ping
Song, Si -Yuan
Wang, Yiping
Wang, Hailian
Cao, Peng
Liu, Yu 'e
Wang, Yi
BIOMEDICINE & PHARMACOTHERAPY, 2024, 174

← 1 2 3 4 5 →